"Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy (vol 12, 717730, 2021)"
作者全名："Wang, Xing; Yin, Guobing; Zhang, Wei; Song, Kunling; Zhang, Longbin; Guo, Zufeng"
作者地址："[Wang, Xing; Yin, Guobing] Chongqing Med Univ, Affiliated Hosp 2, Dept Breast & Thyroid Surg, Chongqing, Peoples R China; [Wang, Xing; Zhang, Wei; Song, Kunling; Zhang, Longbin; Guo, Zufeng] Chongqing Med Univ, Inst Life Sci, Ctr Novel Target & Therapeut Intervent, Chongqing, Peoples R China"
通信作者："Yin, GB (通讯作者)，Chongqing Med Univ, Affiliated Hosp 2, Dept Breast & Thyroid Surg, Chongqing, Peoples R China.; Guo, ZF (通讯作者)，Chongqing Med Univ, Inst Life Sci, Ctr Novel Target & Therapeut Intervent, Chongqing, Peoples R China."
来源：FRONTIERS IN PHARMACOLOGY
ESI学科分类：PHARMACOLOGY & TOXICOLOGY
WOS号：WOS:001004416800001
JCR分区：Q1
影响因子：4.4
年份：2023
卷号：14
期号：
开始页：
结束页：
文献类型：Correction
关键词：PTGR1; tumor metabolism; eicosanoid pathways; cancer therapeutics; inhibitor
摘要：
基金机构：
基金资助正文：
